Welcome to the new Gustave Roussy website
A new website designed to offer you a simpler, clearer, and more intuitive experience. Patients, caregivers, healthcare professionals, and donors: find information, news, and services more easily.
Transatlantic Exchanges: Artificial Intelligence in Oncology on the Program
Join us on May 5th in Paris for a high-level exchange day dedicated to artificial intelligence in oncology, organized by two leaders in the fight against cancer, the Dana-Farber Cancer Institute (United States) and Gustave Roussy.
Published on
Changed on
Join us on May 5th in Paris for a high-level exchange day dedicated to artificial intelligence in oncology, organized by two leaders in the fight against cancer, the Dana-Farber Cancer Institute (United States) and Gustave Roussy.
One year after the success of the first edition in 2022 on the theme of immuno-oncology, the Transatlantic Exchanges are back.
Ranked respectively 3rd and 4th best cancer hospitals in the world, Gustave Roussy and the Dana-Farber Cancer Institute are organizing the second edition of this scientific conference on Artificial Intelligence and Data Science in Oncology, supported by the Servier Institute and broadcast live on the Medscape platform. The objective is to share knowledge and advancements on a rapidly evolving subject.
High-level speakers
This one-day session is co-chaired by Professor Toni Choueiri, director of the Lank Center for Genitourinary Oncology at the Dana-Farber Institute, and Professor Karim Fizazi, medical oncologist and head of the international academic network at Gustave Roussy. The conference will be moderated by Professor Fabrice André, director of research at Gustave Roussy. Among the expected speakers are Eliezer Van Allen, physician, head of the division of population sciences, Professor Franziska Michor, professor of computational biology at the Dana-Farber, and Professor Paul Henry Cournède, director of research at CentraleSupélec, Paris-Saclay University.
The event, which will take place at the Boissière Conference Center in Paris, is open to all healthcare professionals interested in prior registration. Register to participate in-person on the day.
It will also be virtually broadcast on the Medscape platform. Register here.
This program is part of a collaboration agreement between the Dana-Farber Cancer Institute and Gustave Roussy, supported by the Servier Institute. It includes annual conferences alternating between Boston and Paris, as well as a scholarship program for young researchers from Gustave Roussy, who will be hosted in the research laboratories of the Dana-Farber.
Last news
-
Drug shortages: Gustave Roussy becomes the only Cancer Centre in France authorised to produce Special Hospital Preparations
The Clinical Pharmacy Department at Gustave Roussy has been authorised by the French Ministry of Health to manufacture Special Hospital Preparations (SHPs). Granted for a period of seven years, this accreditation enables the Institute’s hospital pharmacy to produce certain medicines in coordination with the French National Agency for the Safety of Medicines and Health Products (ANSM) and the Ministry of Health. Gustave Roussy is the only French Comprehensive Cancer Centre (CLCC) authorised to manufacture Special Hospital Preparations, alongside ten university hospitals.
-
Personalising Breast Cancer Treatments: 5 Questions with Dr Barbara Pistilli
Advances in treatment and patient care mean that five-year net survival for breast cancer now reaches 88%1 in France. However, with around 60,000 new cases diagnosed each year in France alone, breast cancer remains a major public health challenge. One reason is the side effects associated with treatment. In response to this issue, Dr Barbara Pistilli, Head of the Breast Cancer Committee at Gustave Roussy, advocates an approach centred on personalised care, ensuring that each woman receives a treatment intensity tailored to her tumour and individual journey, without compromising her chances of recovery.
-
Breast Cancer: Gustave Roussy Ranked No. 1 in France for Breast Surgery and Breast Reconstruction
On the occasion of Breast Cancer Awareness Month, the 2025 data from Visuchir, the national surgical activity monitoring tool of the French Health Insurance system, places Gustave Roussy in first position for both breast surgery and breast reconstruction. Beyond this ranking, these figures highlight that reconstruction is now an integral part of breast cancer treatment. It is considered at every stage of care: from tumor removal surgery, whether lumpectomy or mastectomy, through to the post-cancer period, helping to restore the body and support women in regaining their physical integrity and quality of life.
-
Newsweek Ranking: Gustave Roussy Named Europe’s Leading Cancer Centre and Third Best Worldwide
The 2027 edition of Newsweek’s World's Best Specialized Hospitals ranking once again recognises Gustave Roussy as the leading cancer centre in France and Europe, and the third best worldwide. This distinction highlights the excellence of the Institute’s care and research, as well as the daily commitment of all its professionals.
